.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Accenture
Boehringer Ingelheim
Merck
Chubb
Argus Health
Julphar
Cipla
Baxter
QuintilesIMS

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Rapamycin formulations for oral administration
Abstract:The present invention comprises oral rapamycin formulations which contain, per 100 ml of the formulation, from about 0.01 to about 10.0 grams per 100 ml of rapamycin, from about 0.1 to about 10 ml of surfactant, from about 0.1 to about 25 ml of N,N-dimethylacetamide, and from about 65 to about 99.8 ml of a lecithin or phospholipid solution.
Inventor(s): Harrison; Maureen M. (St. Albans, VT), Ofslager; Christian L. (Plattsburgh, NY), Waranis; Robert P. (Chazy, NY), Leonard; Thomas W. (Wilmington, NC)
Assignee: American Home Products Corporation (Madison, NJ)
Filing Date:May 23, 1995
Application Number:08/448,280
Claims:1. A composition comprising, per 100 ml composition, from about 0.01 to about 10.0 grams of rapamycin, from about 0.1 to about 10.0 ml of surfactant, from about 0.1 to about 25 ml of N,N-dimethylacetamide, and from about 65 to about 99.8 ml of a 50% lecithin or phospholipid solution.

2. The composition of claim 1 which contains, per 100 ml composition, from about 0.05 to about 5.0 grams of rapamycin, from about 0.5 to about 8.0 ml of surfactant, from about 0.5 to about 20 ml of N,N-dimethylacetamide, and from about 72 to about 99.0 ml of a 50% lecithin or phospholipid solution.

3. A composition of claim 1 which contains, per 100 ml composition, from about 0.10 to about 1.0 grams of rapamycin, from about 1.0 to about 5.0 ml of surfactant, from about 1.0 to about 10 ml of N,N-dimethylacetamide, and from about 85 to about 98.0 ml of a 50% lecithin or phospholipid solution.

4. The composition of claim 1 which is contained within a starch capsule.

5. The composition of claim 1 which is contained within a gelatin capsule.

6. The composition of claim 1 which is dispersed in a liquid.

7. The composition of claim 6 in which the liquid is water.

8. The composition of claim 7 in which the composition of matter is dispersed in water at a concentration in the range of from about 1 part of the compositon of matter into about 9 parts water to about 1 part of the compositon of matter into about 499 parts water.

9. The composition of claim 1 wherein the surfactant is polysorbate 80.

10. A composition comprising, per 100 ml of the composition,

a) a first 20 ml component of 2500 mg of rapamycin in N,N-dimethylacetamide; and

b) a second component of from about 0.05 gm/ml to about 0.07 gm/ml of surfactant in lecithin, the second component being added to the first 20 ml component to complete a 100 ml composition volume.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Medtronic
Farmers Insurance
Harvard Business School
Moodys
Merck
Chinese Patent Office
Fish and Richardson
AstraZeneca
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot